<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "niCARdipine inj BAG">
<dose><value>0.5 - 2</value>
<value>0.5 - 5</value>
<value>5 - 15</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>0.2 mg/mL</value>
</strength>
<frequency><value>CONTINUOUS</value>
</frequency>
<instruction></instruction>
<volume><value>200 mL</value>
</volume>
<units><value>mcg/kg/minute</value>
<value>mg/hour</value>
</units>
<Population><value>NEONATE</value>
<value>CHILDREN</value>
<value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Titrate dose according to blood pressure.</value>
<value>Children aged 1 to 17 years of age. Titrate dose according to blood pressue, rate of infusion may be increased every 15 to 30 minutes. Maximum dose recommended: 4 to 5 mcg/kg/minute.</value>
<value>Initial dose of 5 mg/hour increased by 2.5 mg/hour every 5 minutes (for rapid titration) to every 15 minutes (for gradual titration) up to a maximum dose of 15 mg/hour. For rapidly titrated patients, consider reducing to 3 mg/hour after response is achieved. Initial goal of therapy is to reduce mean arterial BP by no more than 25% within the first hour and then to 160/100-110 mmHg within the next 2 to 6 hours if stable. Titrate dose slowly in patients with renal and liver impairment.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6001</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions. Health Canada Special Access Programme.</value>
</AHSFormularyStatus>
<AHFSName><value>Calcium-Channel Blocking Agents, Dihydropyridines</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>